Lessons from Trial-Based Cost-Effectiveness Analyses of Mental Health Interventions: Why Uncertainty About the Outcome, Estimate and Willingness to Pay Matters

Author： Hoch Jeffrey S.   Dewa Carolyn S.  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.10, 2007-01, pp. : 807-816

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A systematic review of cost-effectiveness analyses of pharmacogenomic interventions

By Phillips Kathryn A   Van Bebber Stephanie L  

Pharmacogenomics, Vol. 5, Iss. 8, 2004-12 ,pp. : 1139-1149

Future Medicine

Access to resources Recommend Favorite

Sample Size and Power for Cost-Effectiveness Analysis (Part 2): The Effect of Maximum Willingness to Pay

By Glick Henry A.  

PharmacoEconomics, Vol. 29, Iss. 4, 2011-04 ,pp. : 287-296

Adis International

Access to resources Recommend Favorite

Societal Discounting of Health Effects in Cost-Effectiveness Analyses: The Influence of Life Expectancy

By Polinder Suzanne  

PharmacoEconomics, Vol. 23, Iss. 8, 2005-01 ,pp. : 791-802

Adis International

Access to resources Recommend Favorite

Handling Uncertainty in Cost-Effectiveness Models

By Briggs A.H.  

PharmacoEconomics, Vol. 17, Iss. 5, 2000-05 ,pp. : 479-500

Adis International

Access to resources Recommend Favorite

Exploring Uncertainty in Cost-Effectiveness Analysis

By Claxton Karl  

PharmacoEconomics, Vol. 26, Iss. 9, 2008-01 ,pp. : 781-798

Adis International

Access to resources Recommend Favorite